scholarly journals Antibacterial Activity of Wild Mushroom Extracts on Bacterial Wilt Pathogen Ralstonia solanacearum

Plant Disease ◽  
2016 ◽  
Vol 100 (2) ◽  
pp. 453-464 ◽  
Author(s):  
Jana Erjavec ◽  
Maja Ravnikar ◽  
Jože Brzin ◽  
Tine Grebenc ◽  
Andrej Blejec ◽  
...  

In total, 150 protein extracts from 94 different basidiomycete and ascomycete wild mushroom species were tested for antibacterial activity against the quarantine plant-pathogen bacterium Ralstonia solanacearum. In in vitro microtiter plate assays, 15 extracts with moderate to high antibacterial activities were identified: 11 completely inhibited bacterial growth and 4 showed partial inhibition. Of these 15 extracts, 5 were further tested and 3 extracts slowed disease progression and reduced disease severity in artificially inoculated tomato and potato plants. However, the in vitro activities of the extracts did not always correlate with their in vivo activities, which emphasizes the importance of performing early screening tests also in vivo. Testing of selected extracts against 12 R. solanacearum strains identified 6 with potential for broader applicability. Further analysis of extracts from Amanita phalloides and Clitocybe geotropa showed that the active substances are proteins with an approximate size of 180 kDa. To our knowledge, this is the first in vitro and in vivo study that demonstrates that mushroom protein extracts can be promising for treatment of bacterial wilt caused by R. solanacearum.

Author(s):  
Lucy N. Karanja ◽  
Isaac O. K’Owino ◽  
Phanice T. Wangila ◽  
Rose C. Ramkat

Aims: To determine the phytochemical composition and antibacterial activity of Solanum incanum fruits against Ralstonia solanacearum. Study Design: Experimental design involving completely randomized design Place and Duration of Study: The study was conducted at department of Chemistry and Biochemistry, School of Sciences and Aerospace studies, Moi University, Kenya, between January and June 2021.   Methodology: Extraction was done by maceration using ethanol as the extracting solvent. Phytochemical screening was done following standard procedures. Total Phenolic Content (TPC) and Total Flavonoid Content (TFC) were determined using the Folin–Ciocalteu colorimetric method and aluminum chloride colorimetric assay respectively. The extract was further analyzed using Gas Chromatography Mass spectroscopy (GC-MS) and Fourier transformed Infrared (FT-IR). In vitro antibacterial activity was determined using disc diffusion method while in vivo studies was done under greenhouse conditions. Results: Phytochemical analysis showed presence of alkaloids, glycosides, steroids, tannins, flavonoids, phenols, saponins and terpenoids. The TPC and TFC were found to be 84.997 ± 0.2 mg GAE/g and 20.535 ± 0.2 mg/g QE of dried sample respectively. GC-MS analysis revealed the presence of 15 compounds, (9E)-1-Methoxy-9-Octadecene (26.85%), 9-Octadecenamide (Z) (21.43%), E-15-Heptadecenal (7.28%), E-14-Hexadecenal (6.28%), 2,4-Di-tert-butylphenol (4.96%) among others. FT-IR analysis revealed presence of OH, C-H, N-H, CO functional groups at wavenumbers 3348 cm-1, 2931 cm-1, 1589 cm-1, and 1218 cm-1 respectively. The antibacterial activity for in vitro studies at concentrations 0.01, 0.05, 0.10, and 0.15 g/10 mL, the diameters of zone of inhibition were 20.75 ± 1.3, 25.75 ± 0.5, 27.25 ± 0.5, and 30.75 ± 0.5 mm respectively. This was comparable (P= .02) to that of ampicillin (positive control) which had zones of inhibition of 26.75 ± 0.5, 28.75 ± 0.5, 31.75 ± 0.4, and 35.00 ± 0.0 mm at the  concentrations respectively. For the in vivo studies the plant extract and ampicillin delayed the development of the disease by eight and ten days post-inoculation respectively while symptoms of bacterial wilt for water treatment (negative control) were observed four days post-inoculation. Conclusion: The plant extract had remarkable antibacterial activity and can be used to make viable formulations to control the devastating bacterial wilt disease.


Plant Disease ◽  
2012 ◽  
Vol 96 (5) ◽  
pp. 687-692 ◽  
Author(s):  
Péninna Deberdt ◽  
Benjamin Perrin ◽  
Régine Coranson-Beaudu ◽  
Pierre-François Duyck ◽  
Emmanuel Wicker

To control bacterial wilt (Ralstonia solanacearum, phylotype IIB/4NPB), the antimicrobial effect of Allium fistulosum aqueous extract was assessed as a preplant soil treatment. Three concentrations of extract (100, 50, and 25%, 1:1 [wt/vol]) were evaluated by in vitro inhibition assay and in vivo experiments in a growth chamber. In vitro, A. fistulosum (100 and 50%) suppressed growth of R. solanacearum. Preplant treatment of the soil with A. fistulosum extract significantly reduced the R. solanacearum populations. No pathogen was detected in the soil after treatment with 100% concentrated extract from the third day after application until the end of the experiment. A. fistulosum also significantly reduced the incidence of tomato bacterial wilt. In the untreated control, the disease affected 61% of the plants whereas, with 100 and 50% extracts, only 6 and 14% of the plants, respectively, were affected. These results suggest that A. fistulosum extracts could be used in biocontrol-based management strategies for bacterial wilt of tomato.


2016 ◽  
Vol 14 (3) ◽  
pp. e1006 ◽  
Author(s):  
Naseerud Din ◽  
Musharaf Ahmad ◽  
Muhammad Siddique ◽  
Asad Ali ◽  
Ishrat Naz ◽  
...  

Phytobiocides are a good alternative to chemicals in managing bacterial diseases including bacterial wilt of tomato caused by Ralstonia solanacearum. In the present research study, finely ground dried powders of seven widely available medicinal plants/weeds species viz., Peganum harmala (esfand or wild rue), Calotropis procera (sodom apple), Melia azedarach (white cedar), Allium sativum (garlic), Adhatoda vasica (malabar nut), Tagetes patula (marigold) and Nerium oleander (oleander) were assessed for their anti-microbial activity, both in-vitro (10% w/v) and in-vivo (10, 20, 30, and 40 g/kg of potted soil) against R. solanacearum. Aqueous extracts (prepared as 10% w/v, soaking for 48-72 h and filtering) of C. procera, A. vasica, and T. patula inhibited the in-vitro growth of the bacterial pathogen over 60% of that produced by the standard antibiotic streptomycin. A. sativum, N. oleander and P. harmala aqueous extracts were less effective while M. azedarach showed no effect against R. solanacearum. The higher dose (40 g/kg of soil) of C. procera, A. vasica and T. patula decreased disease severity quite effectively and increased yield and plant growth characters as much as the standard antibiotic did. No phytotoxicity of medicinal plants powder was observed on tomato plants. Alkaloids, flavonoids, tannins, saponins and terpenoids were detected in the aqueous extracts of T. patula and A. vasica whereas C. procera was found to have only alkaloids, flavonoids, tannins and saponins. Our data suggest that dried powders of T. patula, C. procera and A. vasica (40 g/kg of soil) could be used as an effective component in the integrated disease management programs against bacterial wilt of tomato.


2016 ◽  
Vol 21 (3) ◽  
pp. 131
Author(s):  
S. Y. HARTATI ◽  
E. HADIPOENTYANTI ◽  
AMALIA AMALIA ◽  
NURSALAM NURSALAM

<p>ABSTRAK</p><p>Layu   bakteri  yang   disebabkan   oleh <em>  Ralstonia   solanacearum <br /> </em>merupakan salah satu penyakit penting pada tanaman nilam. Perakitan <br /> varietas nilam tahan terhadap penyakit tersebut yang dilakukan melalui <br /> induksi keragaman somaklonal telah menghasilkan beberapa somaklon <br /> yang tahan terhadap <em>R. solanacearum</em> secara <em>in-vitro</em>. Tujuan penelitian <br /> adalah menguji tingkat ketahanan somaklon tersebut terhadap penyakit <br /> layu  pada  kondisi  rumah  kaca (<em>in-vivo</em>).  Penelitian  disusun  dalam <br /> Rancangan  Acak  Lengkap  dengan 27  perlakuan, 3  ulangan,  dan 10 <br /> tanaman/ulangan. Sebagian akar dari somaklon nilam dilukai (dipotong), <br /> selanjutnya diinokulasi (disiram) dengan suspensi<em> R. solanacearum</em> dengan <br /> berbagai konsentrasi 10<sup>5</sup>, 10<sup>7</sup>, dan 10<sup>9 </sup><em>cfu</em>/ml, sebanyak 50 ml/tanaman. <br /> Hasil penelitian menunjukkan, bahwa somaklon yang diinokulasi dengan <br /> konsentrasi 10<sup>5 </sup><em>cfu</em>/ml, 50  ml/tanaman  semuanya  tidak  menunjukkan <br /> gejala layu. Somaklon yang diinokulasi dengan konsentrasi 107 dan 10<sup>9</sup></p><p><em>cfu</em>/ml,  50 ml/tanaman, sebagian layu dan mati.  Dari somaklon yang</p><p>7</p><p>diinokulasi dengan konsentrasi 10     <em>cfu</em>/ml, 50 ml/tanaman, 8 di antaranya</p><p>menunjukkan respon sangat tahan, 4 tahan, dan 5 agak tahan. Ke 17 <br /> somaklon tersebut mempunyai intensitas penyakit &lt;50% dan semua lebih <br /> tahan dari pada varietas Sidikalang (agak toleran). Dari 17 somaklon yang <br /> diinokulasi dengan konsentrasi 10<sup>9 </sup><em>cfu</em>/ml, 50 ml/tanaman, 2 di antaranya <br /> sangat tahan dan 7 somaklon tahan. Teknik skrining ini dapat digunakan <br /> sebagai  metode  standar  untuk pengujian  ketahanan  nilam  terhadap <br /> penyakit layu.</p><p>Kata kunci:  Skrining  ketahanan,  somaklon,  nilam,  penyakit  layu,<em>  R. solanacearum.</em></p><p><em> </em></p><p><em></em>ABSTRACT</p><p>Resistance-Screening of Patchouli Somaclones on Bacterial Wilt Disease (Ralstonia solanacearum) </p><p>Bacterial wilt caused by <em>Ralstonia solanacearum </em>is one of the most <br /> important  diseases  on patchouli.  The  developing patchouli resistance <br /> varieties against  wilt  disease  conducted  through the  induction  of <br /> somaclonal variation produced resistant patchouli somaclones against <em>R. <br /> </em><em>solanacearum </em>(in-vitro). The aim of this  research was to screen the <br /> resistance of those patchouli somaclones against wilt disease under a glass <br /> house condition (in-vivo). The research was conducted in a Randomized <br /> Completely Design  with 27 treatments, 3  replicates,  and 10  plants/ <br /> replicate. Some roots of the patchouli somaclones were wounded (cut), <br /> then inoculated (drenched)   with <em>  R.   solanacearum</em>  suspension   in <br /> concentration of 10<sup>5</sup>, 10<sup>7</sup>, and 10<sup>9 </sup><em>cfu</em>/ml; 50 ml/plant. The result showed, <br /> that all the patchouli somaclones inoculated with <em>R. solanacearum</em> 10<sup>5 <br /> </sup>cfu/ml, 50 ml/plant were not show any wilt sympthom. Whereas, some <br /> somaclones inoculated with the higher concentration 10<sup>7 </sup>and 109 cfu/ml, 50 ml/plant were wilted and died. Among the somaclones inoculated with  the concentration of 10<sup>7</sup>  cfu/ml, 50 ml/plant, 8 of them were highly  resistant, 4 were resistant, and 5 were moderately resistant. The disease  intencity of those 17 somaclones were &lt;50% and they were more resistant than  the  Sidikalang  variety  (moderately  tolerant).  Among  those  17 <br /> somaclones inoculated with the concentration of 10<sup>9 </sup>cfu/ml, 50 ml/plant, 2 <br /> of them were highly resistant and 7 were resistant. This screening method <br /> could be used as a standard protocol for patchouli resistance screening <br /> against wilt disease.</p><p>Kata kunci: Screening resistance, somaclone, patchouli, wilt disease, <em>R. solanacearum.</em></p>


2020 ◽  
Vol 11 ◽  
pp. 138-145
Author(s):  
N’guessan Aya Carine ◽  
Camara Brahima ◽  
Amari Ler N’Ogn Dadé Georges Elisée ◽  
Doumbouya Mohamed ◽  
Pakora Gilles Alex ◽  
...  

The tomato crop is confronted to numerous soilborne pathogens, including Ralstonia solanacearum, which considerably limits its production. In order to control this bacterium, a biological control approach has been considered by evaluating the efficacy of the NECO biopesticide against this bacteriosis. In vitro confrontations were carried out using a range of five concentrations of the biopesticide. In vivo, NECO solutions of 5 and 10 mL/L were incorporated into soil previously infested with R. solanacearum before transplanting tomato plants. Zones of bacterial growth inhibition were observed after the application of the NECO biopesticide. Results showed that the 20 mL/L concentration resulted in a higher inhibition rate. The biopesticide at the 10 mL/L concentration significantly reduced the incidence of bacterial wilt (54.05%) under in vivo conditions. The NECO biopesticide could be used as a control agent for Ralstonia solanacearum.


2021 ◽  
Vol 12 ◽  
Author(s):  
Shili Li ◽  
Jing Pi ◽  
Hongjiang Zhu ◽  
Liang Yang ◽  
Xingguo Zhang ◽  
...  

In rhizospheres, chemical barrier-forming natural compounds play a key role in preventing pathogenic bacteria from infecting plant roots. Here, we sought to identify specific phenolic exudates in tobacco (Nicotiana tobaccum) plants infected by the soil-borne pathogen Ralstonia solanacearum that may exhibit antibacterial activity and promote plant resistance against pathogens. Among detected phenolic acids, only caffeic acid was significantly induced in infected plants by R. solanacearum relative to healthy plants, and the concentration of caffeic acid reached 1.95 μg/mL. In vivo, caffeic acid at 200 μg/mL was highly active against R. solanacearum and obviously damaged the membrane structure of the R. solanacearum cells, resulting in the thinning of the cell membrane and irregular cavities in cells. Moreover, caffeic acid significantly inhibited biofilm formation by repressing the expression of the lecM and epsE genes. In vitro, caffeic acid could effectively activate phenylalanine ammonia-lyase (PAL) and peroxidase (POD) and promote the accumulation of lignin and hydroxyproline. In pot and field experiments, exogenous applications of caffeic acid significantly reduced and delayed the incidence of tobacco bacterial wilt. Taken together, all these results suggest that caffeic acid played a crucial role in defending against R. solanacearum infection and was a potential and effective antibacterial agent for controlling bacterial wilt.


2021 ◽  
Vol 22 (6) ◽  
pp. 3253
Author(s):  
Clarisse Roblin ◽  
Steve Chiumento ◽  
Cédric Jacqueline ◽  
Eric Pinloche ◽  
Cendrine Nicoletti ◽  
...  

The world is on the verge of a major antibiotic crisis as the emergence of resistant bacteria is increasing, and very few novel molecules have been discovered since the 1960s. In this context, scientists have been exploring alternatives to conventional antibiotics, such as ribosomally synthesized and post-translationally modified peptides (RiPPs). Interestingly, the highly potent in vitro antibacterial activity and safety of ruminococcin C1, a recently discovered RiPP belonging to the sactipeptide subclass, has been demonstrated. The present results show that ruminococcin C1 is efficient at curing infection and at protecting challenged mice from Clostridium perfringens with a lower dose than the conventional antibiotic vancomycin. Moreover, antimicrobial peptide (AMP) is also effective against this pathogen in the complex microbial community of the gut environment, with a selective impact on a few bacterial genera, while maintaining a global homeostasis of the microbiome. In addition, ruminococcin C1 exhibits other biological activities that could be beneficial for human health, as well as other fields of applications. Overall, this study, by using an in vivo infection approach, confirms the antimicrobial clinical potential and highlights the multiple functional properties of ruminococcin C1, thus extending its therapeutic interest.


Author(s):  
Jerzy Karczewski ◽  
Christine M Brown ◽  
Yukari Maezato ◽  
Stephen P Krasucki ◽  
Stephen J Streatfield

Abstract Objectives To evaluate the efficacy of a novel lantibiotic, CMB001, against MRSA biofilms in vitro and in an in vivo experimental model of bacterial infection. Methods Antibacterial activity of CMB001 was measured in vitro after its exposure to whole blood or to platelet-poor plasma. In vitro efficacy of CMB001 against a Staphylococcus aureus biofilm was studied using scanning electron microscopy. The maximum tolerable dose in mice was determined and a preliminary pharmacokinetic analysis for CMB001 was performed in mice. In vivo efficacy was evaluated in a neutropenic mouse thigh model of infection. Results CMB001 maintained its antibacterial activity in the presence of blood or plasma for up to 24 h at 37°C. CMB001 efficiently killed S. aureus within the biofilm by causing significant damage to the bacterial cell wall. The maximum tolerable dose in mice was established to be 10 mg/kg and could be increased to 30 mg/kg in mice pretreated with antihistamines. In neutropenic mice infected with MRSA, treatment with CMB001 reduced the bacterial burden with an efficacy equivalent to that of vancomycin. Conclusions CMB001 offers potential as an alternative treatment option to combat MRSA. It will be of interest to evaluate the in vivo efficacy of CMB001 against infections caused by other pathogens, including Clostridioides difficile and Acinetobacter baumannii, and to expand its pharmacokinetic/pharmacodynamic parameters and safety profile.


Sign in / Sign up

Export Citation Format

Share Document